$ Value
$0
Shares
668
Price
$0
Filed
Jun 4
Insider
Name
Farkas Charles
Title
—
CIK
0001615538
Roles
Transaction Details
Transaction Date
2025-06-02
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
668
Footnotes
The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
Filing Info
Farkas Charles's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-09-12 | CNMD | ▼ | $59K |
| 2025-09-12 | CNMD | ▼ | $48K |
| 2025-06-03 | CNMD | M | $0 |
| 2025-06-03 | CNMD | M | $0 |
| 2025-06-02 | CNMD | A | $0 |
| 2025-06-02 | CNMD | A | $0 |
| 2025-05-29 | CNMD | M | $56K |
| 2025-05-29 | CNMD | F | $56K |
| 2025-05-29 | CNMD | M | $0 |
| 2025-05-05 | CNMD | ▼ | $228K |
Other Insiders at CNMD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Beyer Pat
President & CEO
|
— | — | 2026-04-01 |